Oral Ferrous Sulphate Improves Functional Capacity on Heart Failure Patients with Iron Deficiency Anemia

Background: Iron deficiency anemia (IDA) in heart failure (HF) is associated with poor functional capacity. Several studies reported the benefit of iron therapy in HF with IDA on improving functional capacity. Therefore, we attempt to investigate the effect of oral iron supplementation on functional...

Full description

Bibliographic Details
Main Authors: Lita Dwi Suryani, Sunu Budhi Raharjo, Rima Sagita, Hansen Angkasa, Yosafat Lambang Prasetyadi, Franciscus D. Suyatna, Nani Hersunarti, Rarsari Soerarso, Bambang Budi Siswanto, Hary Sakti Muliawan
Format: Article
Language:English
Published: Ubiquity Press 2022-11-01
Series:Global Heart
Subjects:
Online Access:https://globalheartjournal.com/articles/1151
_version_ 1811199280993533952
author Lita Dwi Suryani
Sunu Budhi Raharjo
Rima Sagita
Hansen Angkasa
Yosafat Lambang Prasetyadi
Franciscus D. Suyatna
Nani Hersunarti
Rarsari Soerarso
Bambang Budi Siswanto
Hary Sakti Muliawan
author_facet Lita Dwi Suryani
Sunu Budhi Raharjo
Rima Sagita
Hansen Angkasa
Yosafat Lambang Prasetyadi
Franciscus D. Suyatna
Nani Hersunarti
Rarsari Soerarso
Bambang Budi Siswanto
Hary Sakti Muliawan
author_sort Lita Dwi Suryani
collection DOAJ
description Background: Iron deficiency anemia (IDA) in heart failure (HF) is associated with poor functional capacity. Several studies reported the benefit of iron therapy in HF with IDA on improving functional capacity. Therefore, we attempt to investigate the effect of oral iron supplementation on functional capacity in HF patients with IDA. Results: Double blind randomized controlled trial was conducted in National Cardiovascular Center Harapan Kita Hospital Universitas Indonesia. A total 54 HFREF patients with IDA were enrolled and randomized to either oral Ferrous Sulphate (FS) 200mg 3 times a day or placebo with 1:1 ratio for 12 weeks. Primary outcome was functional capacity measured by 6-minute walk test. There were 41 participants completed the study (FS n=22, placebo n=19). Ferrous sulphate significantly improved functional capacity changes (46.23+35m vs -13.7+46m, p<0.001, CI -86.8 to -33.2) compared with placebo groups respectively after 12 weeks intervention. Conclusions: Oral FS supplementation for 12 weeks significantly improved functional capacity in HF patients with IDA. Trial registration: clinicaltrials.gov, NCT02998697. Registered 14 December 2016 - Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT02998697
first_indexed 2024-04-12T01:45:16Z
format Article
id doaj.art-c39b13a753014fa7b85ebd0a53c9141c
institution Directory Open Access Journal
issn 2211-8179
language English
last_indexed 2024-04-12T01:45:16Z
publishDate 2022-11-01
publisher Ubiquity Press
record_format Article
series Global Heart
spelling doaj.art-c39b13a753014fa7b85ebd0a53c9141c2022-12-22T03:53:06ZengUbiquity PressGlobal Heart2211-81792022-11-0117110.5334/gh.1151989Oral Ferrous Sulphate Improves Functional Capacity on Heart Failure Patients with Iron Deficiency AnemiaLita Dwi Suryani0Sunu Budhi Raharjo1Rima Sagita2Hansen Angkasa3Yosafat Lambang Prasetyadi4Franciscus D. Suyatna5Nani Hersunarti6Rarsari Soerarso7Bambang Budi Siswanto8Hary Sakti Muliawan9Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia/National Cardiovascular Center Harapan Kita Hospital, Indonesia/Universitas Indonesia HospitalDepartment of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia/National Cardiovascular Center Harapan Kita Hospital, Indonesia/Universitas Indonesia HospitalDepartment of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia/National Cardiovascular Center Harapan Kita Hospital, Indonesia/Universitas Indonesia HospitalDepartment of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia/National Cardiovascular Center Harapan Kita Hospital, Indonesia/Universitas Indonesia HospitalDepartment of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia/National Cardiovascular Center Harapan Kita Hospital, Indonesia/Universitas Indonesia HospitalDepartment of Pharmacology and Therapeutic, Faculty of Medicine, Universitas IndonesiaDepartment of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia/NationaINCardiovascular Center Harapan Kita Hospital, Indonesia/Universitas Indonesia HospitalDepartment of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia/National Cardiovascular Center Harapan Kita Hospital, Indonesia/Universitas Indonesia HospitalDepartment of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia/National Cardiovascular Center Harapan Kita Hospital, Indonesia/Universitas Indonesia HospitalDepartment of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia/National Cardiovascular Center Harapan Kita Hospital, Indonesia/Universitas Indonesia HospitalBackground: Iron deficiency anemia (IDA) in heart failure (HF) is associated with poor functional capacity. Several studies reported the benefit of iron therapy in HF with IDA on improving functional capacity. Therefore, we attempt to investigate the effect of oral iron supplementation on functional capacity in HF patients with IDA. Results: Double blind randomized controlled trial was conducted in National Cardiovascular Center Harapan Kita Hospital Universitas Indonesia. A total 54 HFREF patients with IDA were enrolled and randomized to either oral Ferrous Sulphate (FS) 200mg 3 times a day or placebo with 1:1 ratio for 12 weeks. Primary outcome was functional capacity measured by 6-minute walk test. There were 41 participants completed the study (FS n=22, placebo n=19). Ferrous sulphate significantly improved functional capacity changes (46.23+35m vs -13.7+46m, p<0.001, CI -86.8 to -33.2) compared with placebo groups respectively after 12 weeks intervention. Conclusions: Oral FS supplementation for 12 weeks significantly improved functional capacity in HF patients with IDA. Trial registration: clinicaltrials.gov, NCT02998697. Registered 14 December 2016 - Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT02998697https://globalheartjournal.com/articles/1151heart failure, iron heart failureiron deficiency anemiaoral ferrous sulphatefunctional capacityanemia, oral ferrous sulphate, functional capacity
spellingShingle Lita Dwi Suryani
Sunu Budhi Raharjo
Rima Sagita
Hansen Angkasa
Yosafat Lambang Prasetyadi
Franciscus D. Suyatna
Nani Hersunarti
Rarsari Soerarso
Bambang Budi Siswanto
Hary Sakti Muliawan
Oral Ferrous Sulphate Improves Functional Capacity on Heart Failure Patients with Iron Deficiency Anemia
Global Heart
heart failure, iron heart failure
iron deficiency anemia
oral ferrous sulphate
functional capacityanemia, oral ferrous sulphate, functional capacity
title Oral Ferrous Sulphate Improves Functional Capacity on Heart Failure Patients with Iron Deficiency Anemia
title_full Oral Ferrous Sulphate Improves Functional Capacity on Heart Failure Patients with Iron Deficiency Anemia
title_fullStr Oral Ferrous Sulphate Improves Functional Capacity on Heart Failure Patients with Iron Deficiency Anemia
title_full_unstemmed Oral Ferrous Sulphate Improves Functional Capacity on Heart Failure Patients with Iron Deficiency Anemia
title_short Oral Ferrous Sulphate Improves Functional Capacity on Heart Failure Patients with Iron Deficiency Anemia
title_sort oral ferrous sulphate improves functional capacity on heart failure patients with iron deficiency anemia
topic heart failure, iron heart failure
iron deficiency anemia
oral ferrous sulphate
functional capacityanemia, oral ferrous sulphate, functional capacity
url https://globalheartjournal.com/articles/1151
work_keys_str_mv AT litadwisuryani oralferroussulphateimprovesfunctionalcapacityonheartfailurepatientswithirondeficiencyanemia
AT sunubudhiraharjo oralferroussulphateimprovesfunctionalcapacityonheartfailurepatientswithirondeficiencyanemia
AT rimasagita oralferroussulphateimprovesfunctionalcapacityonheartfailurepatientswithirondeficiencyanemia
AT hansenangkasa oralferroussulphateimprovesfunctionalcapacityonheartfailurepatientswithirondeficiencyanemia
AT yosafatlambangprasetyadi oralferroussulphateimprovesfunctionalcapacityonheartfailurepatientswithirondeficiencyanemia
AT franciscusdsuyatna oralferroussulphateimprovesfunctionalcapacityonheartfailurepatientswithirondeficiencyanemia
AT nanihersunarti oralferroussulphateimprovesfunctionalcapacityonheartfailurepatientswithirondeficiencyanemia
AT rarsarisoerarso oralferroussulphateimprovesfunctionalcapacityonheartfailurepatientswithirondeficiencyanemia
AT bambangbudisiswanto oralferroussulphateimprovesfunctionalcapacityonheartfailurepatientswithirondeficiencyanemia
AT harysaktimuliawan oralferroussulphateimprovesfunctionalcapacityonheartfailurepatientswithirondeficiencyanemia